Why Erasca, Up 415% This Year Amid Revolution-Tied Furor, Just Lost Half Its Value - Investor's Business Daily

Erasca stock crashed Tuesday after a patient in its pancreatic cancer study died following a bout of pneumonia.

You are being redirected to the original discussion. Please continue if you want to read the full post.

Continue to original article

You will be redirected in 3 seconds.